Ukuqubuka kokubaleka kuye kwabangela ukukhathazeka emhlabeni jikelele. Njengabathumeli bangaphandle abakhulu be-API emhlabeni, iphethini yokuhlinzeka yase-China ne-India ithintekile. Ngaso leso sikhathi, ngokuvela komzuliswano omusha wokuvikela ukuhwebelana komhlaba wonke kanye nesidingo esikhulayo sokuphepha kwemboni yezemithi ngenxa yalolu bhubhane, imboni ye-API yaseChina ibhekene nezinselelo ezintsha futhi kufanele isheshise uguquko kanye nokwenza ngcono ukusuka ezweni elikhulu kuye ezweni elikhulu. eqinile. Kuze kube manje, "Izindaba Zezomnotho Zemithi" yethule ngokukhethekile ukuhlela okukhethekile "komgwaqo we-API oya Ezweni Eliqinile".
Unyaka wezi-2020 bekuwunyaka lapho imboni yezemithi emhlabeni wonke yathinteka kakhulu yilolu bhubhane. Futhi bekungunyaka lapho imboni ye-API yaseChina imelana nokuhlolwa kokuguquguquka emakethe yamazwe ngamazwe. Ngokwezibalo zokuqala ze-China Chamber of Commerce for Medical Insurance, ngo-2020, ukuthunyelwa kwe-API yaseChina kwasifinyelela ku-$35.7 billion, elinye irekhodi eliphakeme, nokukhula konyaka cishe ngo-6%.
Ngo-2020, ukukhula kokuthunyelwa kwe-API yaseChina kwagqugquzelwa yilolu bhubhane, okwakhulisa isidingo somhlaba wonke se-ANTI-epidemic APIS, futhi kwathinta nokukhiqizwa kwabanye abakhiqizi abakhulu be-API njenge-India kanye ne-European Union. Ngenxa yalokho, ama-oda okudlulisa e-API yase-China asuka emakethe yamazwe ngamazwe anda. Ngokukhethekile, inani lokuthekelisa le-API yaseChina lenyuke ngo-7.5% unyaka nonyaka, lafinyelela kumathani ayizigidi eziyi-10.88. Kusukela kusigaba esithile sokuthekelisa, anti-infection, amavithamini, amahomoni, i-antipyretic analgesic, ingxenye yokumelana namagciwane esigabeni se-API esihlobene nenani lokuthekelisa ibonwa kakhulu amazinga ahlukene okukhula, ezinye izinhlobo ezithile zikhula ngokushesha, njengokuthunyelwa ngaphandle kwe-dexamethasone rose 55 I-% unyaka nonyaka, i-lamivudine, i-vitamin C, i-vitamin E kanye nezinye izinto ezithunyelwa ngaphandle ngaphezu kuka-30% ukukhula konyaka nonyaka, i-Paracetamol, i-annannin kanye nokunye okuthunyelwa kwamanye amazwe ukukhula konyaka okungaphezu kwama-20%.
Kusukela ngo-Ephreli kulo nyaka, ukuqubuka kwe-COVID-19 e-India kuye kwaba kubi kakhulu, futhi ohulumeni basekhaya sebephendukele ezindleleni ezinjengokuvalwa nokuvalwa. Njengombangi oyinhloko we-API yaseChina emakethe yamazwe ngamazwe, ukuqubuka okukhulu eNdiya kuzothinta ukukhiqizwa okuvamile nokuthunyelwa kwe-API yayo. Kubikwa ukuthi ekuqaleni kuka-Ephreli, uhulumeni waseNdiya umemezele ukuvalwa kokuthunyelwa kwe-redesivir API kanye namalungiselelo okuhlangabezana nezidingo zokubhekana nobhubhane lwezwe, okubangele ukushoda komhlaba wonke kwe-redesivir API. Uma kubhekwa ukuhlinzekwa okungazinzile kwe-APIS e-India, kulindeleke ukuthi Kulo nyaka, Njengonyaka odlule, i-China isengakwazi ukwenza ama-oda okudlulisa ama-API emakethe yamazwe ngamazwe futhi igcine ukukhula okuzinzile kokuthekelisa kwe-API yaseChina.
Kodwa-ke, amathuba okuthekelisa alethwe yilolu bhubhane awesikhashana, futhi ukuthi ungabhekana kanjani nezingozi ezijulile kanye namathuba ngemuva kwalolu bhubhane kuyindaba ephuthumayo yentuthuko yamazwe ngamazwe yesikhathi esizayo yemboni ye-API yaseChina.
Isikhathi sokuthumela: Aug-16-2021